Best DFPP Plasmapheresis Doctors Worldwide — TOP 6

Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.

• National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
• Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
• Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
• Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.

Prof. Dr. Murat Demiroğlu has over 25 years of clinical and academic experience in the field of Orthopedics and Traumatology. He specializes in hand surgery, foot and ankle surgery, arthroplasty, orthopedic oncology, and trauma surgery.

He was born in Istanbul in 1971. He completed his elementary, middle, and high school education in Istanbul. In 1988, he was admitted to Istanbul University’s Istanbul Faculty of Medicine, where he began his medical education, and graduated with a medical degree in 1994.

Between 1994 and 1996, he fulfilled his mandatory service as a general practitioner in Artvin. In 1996, he passed the Medical Specialization Exam (TUS) and began his residency in Orthopedics and Traumatology. In 2001, he completed his residency at Taksim Training and Research Hospital and earned the title of Specialist in Orthopedics and Traumatology.

Following his residency, he completed his mandatory service at Van State Hospital and subsequently worked at Beykoz State Hospital. He later worked as a founding specialist at the Hand Surgery Clinic of Baltalimanı Bone Diseases Training and Research Hospital, where he had the opportunity to work with many experienced surgeons in his field.

As part of his professional development, he served as an observer physician at Mount Sinai Hospital in Chicago, USA. He later worked at Göztepe Training and Research Hospital and was appointed Associate Professor of Orthopedics and Traumatology in 2018.

He retired in 2023 and began working at Florence Nightingale Ataşehir Hospital that same year. In 2024, he was appointed as a professor at Demiroğlu Science University after being promoted to the rank of professor.

After a brief stint at Mecidiyeköy Environmental Hospital, Prof. Dr. Murat Demiroğlu has been serving as a Specialist in Orthopedics and Traumatology at NPİSTANBUL Hospital since June 2026.

He is married and an avid animal lover.

Dr. Pazit Beckerman is the head of the Israeli Dialysis Registry. She works at Sheba Medical Center, a hospital ranked 7th globally. She specializes in chronic kidney disease and complex dialysis management. Dr. Beckerman completed a postdoctoral fellowship at the University of Pennsylvania.

• Served as Acting Director of Nephrology at Sheba Medical Center.
• Treats acute kidney injury and hypertension-related renal disease.
• Expert in glomerular diseases, protein loss, and electrolyte disorders.
• Board member of the Israeli Society of Nephrology and Hypertension.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.